Natco Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

25 Nov 2020 | 03:59 PM

896.60
-16.45 (-1.80%)

  • Outperforms Index

    56.87%

    Return (1Y)

    Beaten S&P BSE Healthcare by 10.54%

  • More Volatile

    2.61%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.92%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

995

995.05

450

450.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Natco Pharma Ltd has decreased by -5.3% since past 3 Months

  • MF shareholding in Natco Pharma Ltd has increased by 6.73% since past 3 Months

  • FII shareholding in Natco Pharma Ltd has decreased by -10.5% since past 1 Year

  • MF shareholding in Natco Pharma Ltd has increased by 25.69% since past 1 Year

Loading...